STOCKWATCH
·
Pharmaceuticals
Quarterly Result7 Aug 2025, 06:02 pm

Innova Captab Reports 19% YoY Revenue Growth in Q1 FY26, EBITDA Grows 28%

AI Summary

Innova Captab Limited, a leading pharmaceutical company, reported strong results for Q1 FY26 with Revenue from Operations at INR 351.5 crore and EBIDTA at INR 56.6 crore. The company registered a YoY revenue growth of 19% and EBIDTA growth of 28%. The PAT increased by 5% YoY to INR 31.0 crore.

Key Highlights

  • Revenue from Operations grew by 19% YoY to INR 351.5 crore
  • Consolidated EBITDA stood at INR 56.6 crore, a YoY growth of 28%
  • EBITDA margins improved to 16.1% from 15.1% in Q1 FY25
  • Profit after Tax (PAT) increased by 5% YoY to INR 31.0 crore
  • Company has reorganized its business areas into two focused verticals: CDMO and Branded Generics
INNOVACAP
Pharmaceuticals
Innova Captab Ltd

Price Impact